Mochida Pharmaceutical Co.,Ltd. Logo

Mochida Pharmaceutical Co.,Ltd.

An R&D-driven company making drugs, skincare, and medical equipment for specialized fields.

4534 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
新宿区四谷一丁目7番地
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Mochida Pharmaceutical Co., Ltd. is a research and development-driven company engaged in the manufacturing and sale of pharmaceuticals, healthcare products, and medical equipment. The company's core pharmaceutical business focuses on developing innovative drugs in targeted therapeutic areas, including cardiovascular medicine, obstetrics and gynecology, psychiatry, and gastroenterology. Its operations span from R&D and manufacturing of various formulations, such as injectables and oral solids, to marketing and sales. In addition to its prescription drug portfolio, Mochida also develops and provides skincare and other healthcare-related products.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Mochida Pharmaceutical Co.,Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-01 03:25
Regulatory News Service
臨時報告書
Japanese 28.8 KB
2025-06-27 06:50
Regulatory News Service
確認書
Japanese 8.7 KB
2025-06-27 06:49
Regulatory News Service
内部統制報告書-第87期(2024/04/01-2025/03/31)
Japanese 24.7 KB
2025-06-27 06:43
Annual Report
有価証券報告書-第87期(2024/04/01-2025/03/31)
Japanese 1.9 MB
2024-11-11 01:36
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-11-11 01:35
Interim Report
半期報告書-第87期(2024/04/01-2025/03/31)
Japanese 192.6 KB
2024-06-28 06:36
Regulatory News Service
臨時報告書
Japanese 28.0 KB
2024-06-27 07:03
Regulatory News Service
確認書
Japanese 8.7 KB
2024-06-27 07:02
Regulatory News Service
内部統制報告書-第86期(2023/04/01-2024/03/31)
Japanese 23.5 KB
2024-06-27 07:01
Annual Report
有価証券報告書-第86期(2023/04/01-2024/03/31)
Japanese 1.5 MB
2024-02-13 02:30
Regulatory News Service
確認書
Japanese 8.7 KB
2024-02-13 02:29
Quarterly Report
四半期報告書-第86期第3四半期(2023/10/01-2023/12/31)
Japanese 161.3 KB
2023-11-13 01:38
Regulatory News Service
確認書
Japanese 8.7 KB
2023-11-13 01:34
Quarterly Report
四半期報告書-第86期第2四半期(2023/07/01-2023/09/30)
Japanese 197.9 KB
2023-08-09 02:20
Regulatory News Service
確認書
Japanese 8.7 KB

Automate Your Workflow. Get a real-time feed of all Mochida Pharmaceutical Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Mochida Pharmaceutical Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
SoftOx Solutions AS Logo
Develops non-toxic, AMR-safe antimicrobials for wound care, disinfection & airway infections.
Norway SOFTX
Solasia Pharma K.K. Logo
In-licenses and commercializes oncology treatments and supportive care products in Asia.
Japan 4597
Sopharma AD Logo
Develops, manufactures, and distributes pharmaceuticals and generics in Bulgaria and regional markets.
Bulgaria SFA
Spago Nanomedical AB Logo
Developing nanomedicines for precise cancer diagnosis and targeted radionuclide therapy.
Sweden SPAGO
Spexis AG Logo
Clinical-stage biopharma developing macrocyclic therapeutics for rare diseases and oncology.
Switzerland SPEX
Sprint Bioscience Logo
Develops & out-licenses preclinical oncology drugs for difficult-to-treat cancers.
Sweden SPRINT
STADA Arzneimittel AG Logo
A leading European manufacturer of generics, consumer healthcare, and specialty pharmaceuticals.
Germany SAZ
Stayble Therapeutics AB Logo
Develops an injectable drug for lumbar disc herniation pain as an alternative to surgery.
Sweden STABL
STCUBE Logo
Develops first-in-class immunotherapies targeting BTN1A1 for treatment-resistant cancers.
South Korea 052020
STELLA PHARMA CORPORATION Logo
Develops boron drugs for Boron Neutron Capture Therapy (BNCT), a targeted cancer radiation treatment.
Japan 4888

Talk to a Data Expert

Have a question? We'll get back to you promptly.